NCT05640531View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

February 7, 2012

Study Completion Date

June 27, 2012

Conditions
Bioavailability
Interventions
DRUG

WCK 771 IV Infusion

subjects will receive intravenous infusion of WCK 771

OTHER

Placebo IV Infusion

subjects will receive matching placebo intravenous infusion

Trial Locations (1)

78744

PPD Phase I Clinic, 7551 Metro Center Drive, Suite 200, Austin

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY

NCT05640531 - Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771 | Biotech Hunter | Biotech Hunter